PHARMACOVIGILANCE 2ND EDITION

Pharmacovigilance 2nd Edition

A Practical Approach

  • A paraître
Written by multidisciplinary experts in the fields of pharmaceutical and patient safety, " Pharmacovigilance: A Practical Approach, 2nd Edition" , provides a succinct, easy-to-digest overview of...

Lire la suite keyboard_arrow_right

Auteur(s) Thao Doan, Fabio Lievano, Linda Scarazzini
Éditeur ELSEVIER HEALTH SCIENCES
Date 28/02/2025
Taille 19 x 23
Type Broché
ISBN 9780443118814

Description détaillée : Pharmacovigilance 2nd Edition

 From cover to cover, this concise resource offers essential information for physicians and other health care professionals, clinical researchers, and regulators who need a comprehensive, up-to-date source of information on the principles and practice of pharmacovigilance.

  • Presents vital, easy-to-read, cutting-edge information on patient safety, the pharmacology regulatory landscape, and the current and future use of digital technologies.
  • Provides up-to-date coverage of hot topics in the field, including pharmacodynamic and safety precision medicine, immunogenicity, vaccine hesitancy and safety, genetic toxicology, and adverse events.
  • Contains new chapters on pre-clinical safety assessment, pharmacogenetics, first-in human trials, product aggregate safety assessment, data monitoring committees, and more.
  • Offers new and expanded coverage of pharmacovigilance in early pre-clinical drug development through post-marketing surveillance, as well as a blueprint for training future pharmacovigilance professionals.
  • Includes real-world case studies to ensure content is relevant and applicable to everyday practice.
  • Discusses a range of topics across disciplines and how they relate to pharmacovigilance, including behavioral science, patient perspectives, and risk communication.
  • An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date.

Re-organized and expanded with 3 new sections and 9 new chapters covering pre-clinical safety assessment, pharmacogenetics, first-in human trials, product aggregate safety assessment, and data monitoring committees.Up-to-date coverage of hot topics in the field, including pharmacodynamic and safety precision medicine, immunogenicity, vaccine hesitancy and safety, genetic toxicology, and adverse events.


Thao Doan : Sr. Medical Director, Medical Safety Evaluation, AbbVie Inc., Chicago. IL, USA
Fabio Lievano : Vice President, Safety Sciences, Medical Safety Evaluation Pharmacovigilance and Patient Safety, AbbVie Inc., Chicago. IL, USA
Linda Scarazzini : Vice President, Pharmacovigilance and Patient Safety, AbbVie Inc., Chicago. IL, USA

À PARAÎTRE OU DERNIÈRE PARUTION DANS LA MÊME CATÉGORIE :

97,00 €

Bientôt disponible

Expédition dès parution

97,00 €
Alerte disponibilité

Bénéficiez de la remise de 5% en choisissant le retrait en magasin

 
Livraison à 0.01€ à partir de 35€

d'achats en France Métropolitaine

 
Satisfait ou remboursé

sous 14 jours ouvrés

 
Paiements sécurisés

 
Service client

Lundi au Vendredi : de 10h à 18h30
au 04 67 63 62 19 ou par email